Can bupropion (Wellbutrin) be added to fluoxetine 80 mg daily for smoking cessation?

Can Bupropion (Wellbutrin) Be Added to Fluoxetine 80 mg for Smoking Cessation?

Yes, bupropion can be added to fluoxetine 80 mg for smoking cessation, but this requires careful monitoring for seizure risk, neuropsychiatric effects, and drug interactions, as the patient is already on a high dose of an SSRI.

Key Safety Considerations

Seizure Risk (Critical)

The maximum recommended dose of bupropion is 300 mg per day 1. Bupropion lowers the seizure threshold with a documented 0.1% seizure risk 1. The FDA label explicitly warns that concomitant use of medications that lower seizure threshold increases risk 2. While fluoxetine itself doesn't dramatically lower seizure threshold, the combination requires heightened vigilance.

Contraindications to avoid:

• History of seizures
• Brain metastases or CNS tumors
• Eating disorders (anorexia/bulimia)
• Abrupt alcohol/benzodiazepine discontinuation
• Concurrent MAO inhibitor use 1, 2

Neuropsychiatric Monitoring

Both medications carry black box warnings for suicidal ideation, though the EAGLES trial (n=8,144) found no significant increase in neuropsychiatric events with bupropion versus placebo 1, 3. However, the FDA label mandates monitoring for agitation, depression worsening, mood changes, psychosis, and suicidal thoughts 2.

Monitor specifically for:

• Agitation, hostility, aggression
• Depressed mood or mania
• Suicidal ideation
• Behavioral changes

Patients should discontinue immediately and contact you if these symptoms emerge 2.

Dosing Algorithm

Standard Bupropion Initiation for Smoking Cessation

• Days 1-3: 150 mg once daily
• Day 4 onward: 150 mg twice daily (if tolerated)
• Maximum: 300 mg/day total 1
• Duration: 7-12 weeks initially, may extend to 6-12 months 1
• Timing: Start 1-2 weeks before target quit date 1

Special Consideration with High-Dose Fluoxetine

The patient is on 80 mg fluoxetine daily—this is double the standard dose. While there's limited specific data on this exact combination at these doses, one small study (n=25) demonstrated safety and modest efficacy (32% abstinence at 9 weeks) when adding bupropion SR 300 mg/day to SSRIs in depressed smokers, with no emergent depression and improvement in SSRI-associated sexual dysfunction 4.

Evidence for Efficacy

Bupropion monotherapy is effective for smoking cessation with an odds ratio of 2.07 (95% CI 1.75-2.45) versus placebo 1 and risk ratio of 1.62 (95% CI 1.49-1.76) across 44 trials 5. The NCCN guidelines list bupropion ± NRT as a preferred primary therapy option 1.

Combination with NRT: The evidence for adding bupropion to NRT shows mixed results—some trials show benefit, others don't 1, 6. A 2014 meta-analysis found only a nonsignificant trend toward improved cessation 1.

Alternative Considerations

Varenicline is superior to bupropion (OR 0.68,95% CI 0.56-0.83 favoring varenicline) 1 and should be considered as first-line if the patient has no contraindications (brain metastases, severe nausea concerns).

Combination NRT (patch + short-acting NRT) is also a preferred first-line option with OR 3.6 (95% CI 2.5-5.2) 6 and may be safer given no drug-drug interaction concerns.

Practical Implementation

1. Screen for contraindications (seizure history, eating disorders, alcohol abuse)
2. Counsel patient on seizure risk, neuropsychiatric symptoms, and need for immediate reporting
3. Start bupropion 150 mg daily for 3 days, then increase to 150 mg twice daily
4. Set quit date 1-2 weeks after starting bupropion
5. Monitor weekly for first month: mood, behavior, side effects
6. Continue for 7-12 weeks minimum; consider extending to 6 months
7. Minimize alcohol use during treatment 2

Common Pitfalls

• Don't exceed 300 mg/day bupropion total regardless of other medications
• Don't combine with other bupropion products (Zyban, Wellbutrin SR/IR, Aplenzin) 2
• Don't ignore dry mouth and insomnia—these are dose-related and common 6
• Don't assume depression will worsen—the study in SSRI-maintained patients showed no emergent depression 4

Bottom line: This combination can be used safely with appropriate monitoring, though varenicline or combination NRT may be preferable first-line options given superior efficacy and fewer drug interaction concerns.